
IDEAYA Biosciences, Inc. — Investor Relations & Filings
IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3ASR - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-13 | English | |
| 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-09 | English | |
| SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-03-27 | English | |
| 4 - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-03-03 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41528732 | S-3ASR - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | ||
| 41325620 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-05-05 | English | ||
| 34403025 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-13 | English | ||
| 33898483 | 8-K - IDEAYA Biosciences, Inc. (0001676725) (Filer) | 2026-04-09 | English | ||
| 33061067 | SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-03-27 | English | ||
| 32896471 | 4 - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-03-03 | English | ||
| 32896472 | 8-K - IDEAYA BIOSCIENCES, INC. (0001676725) (Filer) | 2026-02-17 | English | ||
| 31258355 | 10-K Filing | 2026-02-17 | English | ||
| 31258163 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 19424576 | SCHEDULE 13G/A - IDEAYA Biosciences, Inc. (0001676725) (Subject) | 2026-02-12 | English | ||
| 31258199 | 4 Filing | 2026-02-02 | English | ||
| 31258190 | 4 Filing | 2026-02-02 | English | ||
| 31258189 | 4 Filing | 2026-02-02 | English | ||
| 31258159 | 4 Filing | 2026-02-02 | English | ||
| 31258156 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
IDEAYA Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IDEAYA Biosciences, Inc. (id: 31547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.